Fibroblast growth factor 21 Ameliorates diabetes-induced endothelial dysfunction in mouse aorta via activation of the CaMKK2/AMPKα signaling pathway
Authors:
Open Access
- 11 September 2019
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 10 (9) , 1-12
Abstract
Endothelial dysfunction initiates and exacerbates hypertension, atherosclerosis and other cardiovascular complications in diabetic mellitus. FGF21 is a hormone that mediates a number of beneficial effects relevant to metabolic disorders and their associated complications. Nevertheless, it remains unclear as to whether FGF21 ameliorates endothelial dysfunction. Therefore, we investigated the effect of FGF21 on endothelial function in both type 1 and type 2 diabetes. We found that FGF21 reduced hyperglycemia and ameliorated insulin resistance in type 2 diabetic mice, an effect that was totally lost in type 1 diabetic mice. However, FGF21 activated AMPKα, suppressing oxidative stress and enhancing endothelium-dependent vasorelaxation of aorta in both types, suggesting a mechanism that is independent of its glucose-lowering and insulin-sensitizing effects. In vitro, we identified a direct action of FGF21 on endothelial cells of the aorta, in which it bounds to FGF receptors to alleviate impaired endothelial function challenged with high glucose. Furthermore, the CaMKK2-AMPKα signaling pathway was activated to suppress oxidative stress. Apart from its anti-oxidative capacity, FGF21 activated eNOS to dilate the aorta via CaMKK2/AMPKα activation. Our data suggest expanded potential uses of FGF21 for the treatment of vascular diseases in diabetes.Keywords
Funding Information
- Science and Technology Department of Zhejiang Province (LY18H070002, LQ13H020006)
- Wenzhou Municipal Science and Technology Bureau (Y20140660, Y20160097, Y20180063)
- National Natural Science Foundation of China (81400273)
- National Science Foundation of China | Key Programme (2017YFA0506000, 2017YFA0506000, 2017YFA0506000)
- National Science Foundation of China | Major Research Plan (81473261, 81874323)
This publication has 50 references indexed in Scilit:
- Endothelium-Selective Activation of AMP-Activated Protein Kinase Prevents Diabetes Mellitus–Induced Impairment in Vascular Function and Reendothelialization via Induction of Heme Oxygenase-1 in MiceCirculation, 2012
- Nrf-2 overexpression in mesenchymal stem cells reduces oxidative stress-induced apoptosis and cytotoxicityCell Stress and Chaperones, 2012
- Thermogenic Activation Induces FGF21 Expression and Release in Brown Adipose TissueJournal of Biological Chemistry, 2011
- Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult MouseMolecular Endocrinology, 2010
- Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant StateDiabetes, 2010
- Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implicationsReviews in Endocrine and Metabolic Disorders, 2010
- Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21Cell Metabolism, 2007
- Mechanisms linking obesity to insulin resistance and type 2 diabetesNature, 2006
- Receptor Specificity of the Fibroblast Growth Factor FamilyJournal of Biological Chemistry, 2006
- FGF-21 as a novel metabolic regulatorJournal of Clinical Investigation, 2005